全文获取类型
收费全文 | 26946篇 |
免费 | 2168篇 |
国内免费 | 682篇 |
专业分类
耳鼻咽喉 | 191篇 |
儿科学 | 1282篇 |
妇产科学 | 783篇 |
基础医学 | 2120篇 |
口腔科学 | 308篇 |
临床医学 | 2451篇 |
内科学 | 4985篇 |
皮肤病学 | 255篇 |
神经病学 | 987篇 |
特种医学 | 1182篇 |
外国民族医学 | 2篇 |
外科学 | 2692篇 |
综合类 | 2530篇 |
现状与发展 | 2篇 |
预防医学 | 3960篇 |
眼科学 | 224篇 |
药学 | 3670篇 |
7篇 | |
中国医学 | 976篇 |
肿瘤学 | 1189篇 |
出版年
2024年 | 32篇 |
2023年 | 562篇 |
2022年 | 938篇 |
2021年 | 1488篇 |
2020年 | 1326篇 |
2019年 | 1382篇 |
2018年 | 1254篇 |
2017年 | 1020篇 |
2016年 | 914篇 |
2015年 | 936篇 |
2014年 | 1957篇 |
2013年 | 1925篇 |
2012年 | 1531篇 |
2011年 | 1845篇 |
2010年 | 1459篇 |
2009年 | 1479篇 |
2008年 | 1459篇 |
2007年 | 1452篇 |
2006年 | 1093篇 |
2005年 | 969篇 |
2004年 | 782篇 |
2003年 | 580篇 |
2002年 | 452篇 |
2001年 | 411篇 |
2000年 | 321篇 |
1999年 | 271篇 |
1998年 | 207篇 |
1997年 | 203篇 |
1996年 | 181篇 |
1995年 | 159篇 |
1994年 | 137篇 |
1993年 | 115篇 |
1992年 | 98篇 |
1991年 | 117篇 |
1990年 | 98篇 |
1989年 | 73篇 |
1988年 | 67篇 |
1987年 | 48篇 |
1986年 | 54篇 |
1985年 | 69篇 |
1984年 | 60篇 |
1983年 | 53篇 |
1982年 | 48篇 |
1981年 | 38篇 |
1980年 | 30篇 |
1979年 | 33篇 |
1978年 | 24篇 |
1977年 | 10篇 |
1976年 | 12篇 |
1973年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
《药学学报(英文版)》2020,10(8):1453-1475
Angiokinases, such as vascular endothelial-, fibroblast- and platelet-derived growth factor receptors (VEGFRs, FGFRs and PDGFRs) play crucial roles in tumor angiogenesis. Anti-angiogenesis therapy using multi-angiokinase inhibitor has achieved great success in recent years. In this study, we presented the design, synthesis, target identification, molecular mechanism, pharmacodynamics (PD) and pharmacokinetics (PK) research of a novel triple-angiokinase inhibitor WXFL-152. WXFL-152, identified from a series of 4-oxyquinoline derivatives based on a structure–activity relationship study, inhibited the proliferation of vascular endothelial cells (ECs) and pericytes by blocking the angiokinase signals VEGF/VEGFR2, FGF/FGFRs and PDGF/PDGFRβ simultaneously in vitro. Significant anticancer effects of WXFL-152 were confirmed in multiple preclinical tumor xenograft models, including a patient-derived tumor xenograft (PDX) model. Pharmacokinetic studies of WXFL-152 demonstrated high favourable bioavailability with single-dose and continuous multi-dose by oral administration in rats and beagles. In conclusion, WXFL-152, which is currently in phase Ib clinical trials, is a novel and effective triple-angiokinase inhibitor with clear PD and PK in tumor therapy. 相似文献
73.
双层探测器光谱CT(SDCT)具有上下两层空间对等的探测器结构,使高、低能2套数据在原始数据域空间即被解析,可用于重建反映康普顿效应和光电效应不同组成的能谱图像,并可合并重建完全等同于普通CT所具有的常规多能图像。SDCT的能谱数据具有同时、同源、同向特征,提升了其在心脏成像中的应用价值。本文对SDCT在改善冠状动脉CTA图像质量、“双低”成像、显示斑块及支架以及心肌灌注方面的应用价值进行综述。 相似文献
74.
75.
《Journal of Pharmaceutical Analysis》2022,12(1):178-185
Diagnosing Alzheimer's disease (AD) in the early stage is challenging. Informative biomarkers can be of great value for population-based screening. Metabolomics studies have been used to find potential biomarkers, but commonly used tissue sources can be difficult to obtain. The objective of this study was to determine the potential utility of erythrocyte metabolite profiles in screening for AD. Unlike some commonly-used sources such as cerebrospinal fluid and brain tissue, erythrocytes are plentiful and easily accessed. Moreover, erythrocytes are metabolically active, a feature that distinguishes this sample source from other bodily fluids like plasma and urine. In this preliminary pilot study, the erythrocyte metabolomes of 10 histopathologically confirmed AD patients and 10 patients without AD (control (CTRL)) were compared. Whole blood was collected post-mortem and erythrocytes were analyzed using ultra-performance liquid chromatography tandem mass spectrometry. Over 750 metabolites were identified in AD and CTRL erythrocytes. Seven were increased in AD while 24 were decreased (P<0.05). The majority of the metabolites increased in AD were associated with amino acid metabolism and all of the decreased metabolites were associated with lipid metabolism. Prominent among the potential biomarkers were 10 sphingolipid or sphingolipid-related species that were consistently decreased in AD patients. Sphingolipids have been previously implicated in AD and other neurological conditions. Furthermore, previous studies have shown that erythrocyte sphingolipid concentrations vary widely in normal, healthy adults. Together, these observations suggest that certain erythrocyte lipid phenotypes could be markers of risk for development of AD. 相似文献
76.
77.
78.
79.
80.